Research findings could bolster the effectiveness of immune-checkpoint therapy
Immune checkpoint inhibitors such as Keytruda and Opdivo work by unleashing the immune system's T cells to attack tumor cells. ...
Tag: Small Cell Lung Cancer
Phase III ADAURA trial reveals promising results for patients with non-small cell lung cancer
Newly released results from the Phase III ADAURA trial reveal that osimertinib yielded a 5.5-year median disease-free survival in the ...
Comprehensive genetic architecture atlas compiled for mutant RAS genes in cancers
Researchers at the Johns Hopkins Kimmel Cancer Center, three other cancer centers and the Johns Hopkins Bloomberg School of Public ...
NRG Oncology study of atezolizumab and chemoradiation for patients with limited-stage small cell lung cancer completes accrual
The NRG Oncology/Alliance clinical trial NRG-LU005, examining the addition of the immunotherapy drug atezolizumab combined with chemoradiation for patients with ...
Study provides better understanding of how therapeutic resistance develops in lung cancer
New Cleveland Clinic research has uncovered key information about cellular interaction between tumor cells and normal tissue, providing better understanding ...
Area-level education and income linked with patients' lung cancer stage at the time of diagnosis
Lung cancer is the leading cause of cancer-related deaths in the United States, and early detection and treatment are key ...
Researchers identify predictive biomarkers to fight against non-small cell lung cancer
In a recent study, researchers at the University of Missouri are identifying new minimally invasive biomarkers to develop a blood ...
Blood-based biomarker can predict the benefit of immunotherapy to lung cancer patients
A blood-based tumor biomarker can predict the benefit of immunotherapy to patients with non-small cell lung cancer, in accordance to ...